The CONSORT statement: revised recommendations for improving the quality of reports of parallel group randomized trials
نویسندگان
چکیده
To comprehend the results of a randomized, controlled trial (RCT), readers must understand its design, conduct, analysis, and interpretation. That goal can be achieved only through complete transparency from authors. Despite several decades of educational efforts, the reporting of RCTs needs improvement. Investigators and editors developed the original CONSORT (Consolidated Standards of Reporting Trials) statement to help authors improve reporting by using a checklist and flow diagram. The revised CONSORT statement presented in this paper incorporates new evidence and addresses some criticisms of the original statement. The checklist items pertain to the content of the Title, Abstract, Introduction, Methods, Results, and Discussion. The revised checklist includes 22 items selected because empirical evidence indicates that not reporting the information is associated with biased estimates of treatment effect or because the information is essential to judge the reliability or relevance of the findings. We intended the flow diagram to depict the passage of participants through an RCT. The revised flow diagram depicts information from four stages of trial (enrollment, intervention allocation, follow-up, and analysis). The diagram explicitly includes the number of participants, for each intervention group, that are included in the primary data analysis. Inclusion of these numbers allows the reader to judge whether the authors have performed an intention-to-treat analysis. In sum, the CONSORT statement is intended to improve the reporting of an RCT, enabling readers to understand a trial's conduct and to assess the validity of its results.
منابع مشابه
Adherence to the CONSORT Statement in the Reporting of Randomized Controlled Trials on Pharmacological Interventions Published in Iranian Medical Journals
Background: Among manuscripts submitted to biomedical journals, randomized controlled trials (RCTs) form the backbone of evidence-based medicine. Hence, their protocol should be designed rigorously and their results should be reported clearly. To improve the quality of RCT reporting, researchers developed the CONSORT Statement in 1996 and updated it in 2010. This study was designed to assess th...
متن کاملTGFBR1*6A and cancer: a meta-analysis of 12 case-control studies.
REFERENCES 1. Fisch MJ, Loehrer PJ, Kristeller J, et al: Fluoxetine versus placebo in advanced cancer outpatients: A double-blinded trial of the Hoosier Oncology Group. J Clin Oncol 21:1937-1943, 2003 2. Williams JW Jr, Noel PH, Cordes JA, et al: Is this patient clinically depressed? JAMA 287:1160-1170, 2002 3. Altman DG, Schultz KF, Moher D, et al: The revised CONSORT statement for reporting r...
متن کاملCONSORT in China: past development and future direction
The Consolidated Standards of Reporting Trials (CONSORT) Statement was published in 1996, and first introduced to China in 2001. Although CONSORT has been widely accepted in high-quality international journals, we still need to have more investigation on how many Chinese journals have adopted the CONSORT Statement, and whether the quality of reporting has improved. A systematic search of the "I...
متن کاملSPECIAL COMMUNICATION Reporting of Noninferiority and Equivalence Randomized Trials An Extension of the CONSORT Statement
THE CONSOLIDATED STANdards of Reporting Trials (CONSORT) statement was developed to alleviate the problem of inadequate reporting of randomized controlled trials (RCTs), which has been associated with biased treatment effects. The statement comprises evidence-based recommendations for reporting RCTs, including a flowchart of participants through the trial. CONSORT’s primary focus is on parallel...
متن کاملCONSORT 2010 Explanation and Elaboration: updated guidelines for reporting parallel group randomised trials
Overwhelming evidence shows the quality of reporting of randomised controlled trials (RCTs) is not optimal. Without transparent reporting, readers cannot judge the reliability and validity of trial findings nor extract information for systematic reviews. Recent methodological analyses indicate that inadequate reporting and design are associated with biased estimates of treatment effects. Such s...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید
ثبت ناماگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید
ورودعنوان ژورنال:
- BMC Medical Research Methodology
دوره 1 شماره
صفحات -
تاریخ انتشار 2001